000 | 01941 a2200553 4500 | ||
---|---|---|---|
005 | 20250517133652.0 | ||
264 | 0 | _c20171011 | |
008 | 201710s 0 0 eng d | ||
022 | _a1742-2094 | ||
024 | 7 |
_a10.1186/s12974-016-0770-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKasanmoentalib, E Soemirien | |
245 | 0 | 0 |
_aMannose-binding lectin-associated serine protease 2 (MASP-2) contributes to poor disease outcome in humans and mice with pneumococcal meningitis. _h[electronic resource] |
260 |
_bJournal of neuroinflammation _c01 2017 |
||
300 |
_a2 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 |
_aAntibodies _xadverse effects |
650 | 0 | 4 |
_aCeftriaxone _xpharmacology |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 |
_aCytokines _xgenetics |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFreund's Adjuvant _xadverse effects |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aGlasgow Outcome Scale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMannose-Binding Protein-Associated Serine Proteases _xcerebrospinal fluid |
650 | 0 | 4 |
_aMeningitis, Pneumococcal _xcerebrospinal fluid |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aValls Seron, Mercedes | |
700 | 1 | _aFerwerda, Bart | |
700 | 1 | _aTanck, Michael W | |
700 | 1 | _aZwinderman, Aeilko H | |
700 | 1 | _aBaas, Frank | |
700 | 1 | _avan der Ende, Arie | |
700 | 1 | _aSchwaeble, William J | |
700 | 1 | _aBrouwer, Matthijs C | |
700 | 1 | _avan de Beek, Diederik | |
773 | 0 |
_tJournal of neuroinflammation _gvol. 14 _gno. 1 _gp. 2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12974-016-0770-9 _zAvailable from publisher's website |
999 |
_c26783798 _d26783798 |